Literature DB >> 11223028

Negative regulation of receptor tyrosine kinase signals.

M Fiorini1, M Alimandi, L Fiorentino, G Sala, O Segatto.   

Abstract

In Metazoans a number of cellular functions are controlled by receptor tyrosine kinases (RTKs) during development and in postnatal life. The execution of these programs requires that signals of adequate strength are delivered for the appropriate time within precise spatial boundaries. Several RTK inhibitors have been identified in invertebrate and mammalian organisms. Because they are involved in tuning and termination of receptor signals, negative regulators of RTK activity fulfill a fundamental function in the control of receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11223028     DOI: 10.1016/s0014-5793(01)02116-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis.

Authors:  Mingming Zhao; Justyna A Janas; Masaru Niki; Pier Paolo Pandolfi; Linda Van Aelst
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

2.  Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk.

Authors:  Paul Van Slyke; Mariano Loza Coll; Zubin Master; Harold Kim; Jorge Filmus; Daniel J Dumont
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 3.  ErbB receptor negative regulatory mechanisms: implications in cancer.

Authors:  Colleen Sweeney; Jamie K Miller; David L Shattuck; Kermit L Carraway
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-01       Impact factor: 2.673

4.  Regulation of sprouty stability by Mnk1-dependent phosphorylation.

Authors:  John DaSilva; Lizhong Xu; Hong Joo Kim; W Todd Miller; Dafna Bar-Sagi
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

5.  RNF121 Inhibits Angiogenic Growth Factor Signaling by Restricting Cell Surface Expression of VEGFR-2.

Authors:  Armin Maghsoudlou; Rosana D Meyer; Kobra Rezazadeh; Emad Arafa; Jeffrey Pudney; Edward Hartsough; Nader Rahimi
Journal:  Traffic       Date:  2015-12-21       Impact factor: 6.215

6.  Targeted expression of RALT in mouse skin inhibits epidermal growth factor receptor signalling and generates a Waved-like phenotype.

Authors:  Costanza Ballarò; Sara Ceccarelli; Cecilia Tiveron; Laura Tatangelo; Anna Maria Salvatore; Oreste Segatto; Stefano Alemà
Journal:  EMBO Rep       Date:  2005-08       Impact factor: 8.807

7.  In vivo evidence of htid suppressive activity on ErbB-2 in breast cancers over expressing the receptor.

Authors:  Ursula Kurzik-Dumke; Manuela Hörner; Maria R Nicotra; Michael Koslowski; Pier G Natali
Journal:  J Transl Med       Date:  2010-06-17       Impact factor: 5.531

8.  The Drosophila SH2B family adaptor Lnk acts in parallel to chico in the insulin signaling pathway.

Authors:  Christian Werz; Katja Köhler; Ernst Hafen; Hugo Stocker
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

Review 9.  All Good Things Must End: Termination of Receptor Tyrosine Kinase Signal.

Authors:  Azzurra Margiotta
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

10.  N-linked glycosylation supports cross-talk between receptor tyrosine kinases and androgen receptor.

Authors:  Harri M Itkonen; Ian G Mills
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.